Bettina E. Hansen

Research interests

Publications

• Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)

  Gastroenterology · 2021 · https://doi.org/10.1053/j.gastro.2021.11.002

• Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

  Journal of Hepatology · 2019 · 10.1016/j.jhep.2019.04.001

• Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

  Journal of Hepatology · 2019 · 10.1016/j.jhep.2019.04.001

• The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B

  Hepatology · 2017 · 10.1002/hep.29320

• The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B

  Hepatology · 2017 · 10.1002/hep.29320

• Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

  Gastroenterology · 2017 · https://doi.org/10.1053/j.gastro.2017.02.038

• A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

  New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1509840

• Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication

  Journal of Hepatology · 2016 · 10.1016/j.jhep.2016.10.017

• Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication

  Journal of Hepatology · 2016 · 10.1016/j.jhep.2016.10.017

• Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study

  Hepatology · 2015 · 10.1002/hep.27981

• Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy

  Journal of Hepatology · 2015 · 10.1016/j.jhep.2015.01.002

• PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

  Journal of Hepatology · 2015 · 10.1016/j.jhep.2015.11.035

• PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

  Journal of Hepatology · 2015 · 10.1016/j.jhep.2015.11.035

• Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy

  Journal of Hepatology · 2015 · 10.1016/j.jhep.2015.01.002

• Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

  Gastroenterology · 2015 · 10.1053/j.gastro.2015.07.061

• Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study

  Hepatology · 2015 · 10.1002/hep.27981

• Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

  Gastroenterology · 2015 · 10.1053/j.gastro.2015.07.061

• Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study

  Gastroenterology · 2014 · 10.1053/j.gastro.2014.08.029

• Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study

  Gastroenterology · 2014 · 10.1053/j.gastro.2014.08.029

• Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

  Gut · 2013 · 10.1136/gutjnl-2013-304488

• Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

  Gut · 2013 · 10.1136/gutjnl-2013-304488

• External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study

  Clinical Gastroenterology and Hepatology · 2013 · 10.1016/j.cgh.2012.12.031

• External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study

  Clinical Gastroenterology and Hepatology · 2013 · 10.1016/j.cgh.2012.12.031

• Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

  JAMA · 2012 · https://doi.org/10.1001/jama.2012.144878

• Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam study

  Journal of Hepatology · 2012 · 10.1016/j.jhep.2012.07.028

• Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam study

  Journal of Hepatology · 2012 · 10.1016/j.jhep.2012.07.028

• Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B

  Gastroenterology · 2011 · https://doi.org/10.1053/j.gastro.2011.11.025

• Prediction of Sustained Response to Peginterferon Alfa-2b for Hepatitis B e Antigen–Positive Chronic Hepatitis B Using on-Treatment Hepatitis B Surface Antigen Decline

  Hepatology · 2010 · 10.1002/hep.23844

• Prediction of Sustained Response to Peginterferon Alfa-2b for Hepatitis B e Antigen–Positive Chronic Hepatitis B Using on-Treatment Hepatitis B Surface Antigen Decline

  Hepatology · 2010 · 10.1002/hep.23844

• Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa

  Gastroenterology · 2009 · 10.1053/j.gastro.2009.08.061

• Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid

  Gastroenterology · 2009 · 10.1053/j.gastro.2009.01.003

• Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa

  Gastroenterology · 2009 · 10.1053/j.gastro.2009.08.061

• Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid

  Gastroenterology · 2009 · 10.1053/j.gastro.2009.01.003

• Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b

  Gastroenterology · 2008 · 10.1053/j.gastro.2008.05.031

• Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

  Hepatology · 2008 · https://doi.org/10.1002/hep.22251

• Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b

  Gastroenterology · 2008 · 10.1053/j.gastro.2008.05.031

• Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis

  Annals of Internal Medicine · 2007 · 10.7326/0003-4819-147-10-200711200-00003

• Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis

  Annals of Internal Medicine · 2007 · 10.7326/0003-4819-147-10-200711200-00003

• Treatment with Peg-Interferon alpha-2b for HBeAg-Positive Chronic Hepatitis B: HBsAg Loss Is Associated with HBV Genotype

  The American Journal of Gastroenterology · 2006 · 10.1111/j.1572-0241.2006.00418.x

• Treatment with Peg-Interferon alpha-2b for HBeAg-Positive Chronic Hepatitis B: HBsAg Loss Is Associated with HBV Genotype

  The American Journal of Gastroenterology · 2006 · 10.1111/j.1572-0241.2006.00418.x

• Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

  The Lancet · 2005 · https://doi.org/10.1016/s0140-6736(05)17701-0

• Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome

  Hepatology · 2004 · 10.1002/hep.20064

• Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B

  Hepatology · 2004 · 10.1002/hep.20128

• Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome

  Hepatology · 2004 · 10.1002/hep.20064

• Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B

  Hepatology · 2004 · 10.1002/hep.20128

• Quantification of right ventricular function with magnetic resonance imaging in children with normal hearts and with congenital heart disease

  American Heart Journal · 1995 · https://doi.org/10.1016/0002-8703(95)90084-5

• Comparison of echocardiographic methods with magnetic resonance imaging for assessment of right ventricular function in children

  The American Journal of Cardiology · 1995 · 10.1016/s0002-9149(99)80161-1

• Comparison of echocardiographic methods with magnetic resonance imaging for assessment of right ventricular function in children

  The American Journal of Cardiology · 1995 · 10.1016/s0002-9149(99)80161-1

Current projects

No projects listed.